Ticker Details
TransMedics Group, Inc.
IPO Date:	April 29, 2019
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$3.29B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.81 | 3.13%
Avg Daily Range (30 D):	$2.03 | 2.52%
Avg Daily Range (90 D):	$2.34 | 2.84%

Institutional Daily Volume
Avg Daily Volume:	.56M
Avg Daily Volume (30 D):	.77M
Avg Daily Volume (90 D):	1.05M

Trade Size
Avg Trade Size (Sh.):	49
Avg Trade Size (Sh.) (30 D):	41
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	3,455
Avg Institutional Trade:	$3.82M
Avg Institutional Trade (30 D):	$4.06M
Avg Institutional Trade (90 D):	$3.68M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$6.43M
Avg Closing Trade (30 D):	$8.03M
Avg Closing Trade (90 D):	$8.82M
Avg Closing Volume:	69.95K

News

Aug 9, 2026 @ 2:00 PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Micro... Source: Rosen Law Firm

Aug 9, 2026 @ 3:49 AM TransMedics Group, Inc. Investor News: Rosen Law F... Source: Rosen Law Firm

Aug 5, 2026 @ 5:17 PM Why TransMedics Stock Is Sinking Today Source: Josh Kohn-Lindquist

Jul 17, 2026 @ 12:36 PM Atlas Healthcare Fund by VST Capital Entered Eli L... Source: Vst Capital

Jul 3, 2026 @ 3:15 PM Where Will TransMedics Group Stock Be in 10 Years?... Source: Micah Zimmerman

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$4.44	$.42	$.21
Diluted EPS	$3.86	$.41	$.2
Revenue	$668.47M	$189.95M	$173.93M
Gross Profit	$392.35M	$113.2M	$101.16M
Net Income / Loss	$151.7M	$14.68M	$7.32M
Operating Income / Loss	$81.61M	$23.74M	$13.3M
Cost of Revenue	$276.12M	$76.75M	$72.77M
Net Cash Flow	$90.04M	$10.94M	$-8.69M
PE Ratio